Context: The COVID-19 pandemic highlighted global health inequalities, prompting policymakers worldwide to advocate for enhanced global health infrastructure as a means to drive economic growth and ensure planetary well-being. However, amid these critical efforts, prioritizing access to blood and its products is deemed essential for establishing a robust global health architecture.
The issue of blood shortage
Implications:
Solutions: